---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-029417"
form_type: "8-K"
ticker: "RYTM"
cik: "0001649904"
company_name: "RHYTHM PHARMACEUTICALS, INC."
filed_at: "2024-02-29T23:59:59+00:00"
generated_at: "2026-06-05T06:47:18.006606+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Rhythm Pharmaceuticals amends sales agreement to allow up to $200M in at-the-market stock offerings

## Summary
- Amendment increases ATM offering limit from $100M to $200M, excluding $50M already sold.
- Company had $50M in prior sales as of Feb 29, 2024; new capacity starts from zero.
- No specific use of proceeds disclosed; typical for general corporate purposes.

## SEC filing metadata
- accession: 0001104659-24-029417
- form_type: 8-K
- ticker: RYTM
- cik: 0001649904
- company_name: RHYTHM PHARMACEUTICALS, INC.
- filed_at: 2024-02-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649904/000110465924029417/0001104659-24-029417-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649904/000110465924029417/tm247530d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-029417
- JSON: https://secwatch.observer/filing/0001104659-24-029417.json
- Plain text: https://secwatch.observer/filing/0001104659-24-029417.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.